Belvedere Trading »

Aquestive Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2025-12-31 $112k 17k 6.46

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Southern Company (SO)
Meta Platforms Cl A Call Option (META)
Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Advanced Micro Devices (AMD)
Spdr Gold Tr Gold SHS (GLD)
Amazon (AMZN)
Broadcom (AVGO)
Palantir Technologies Cl A (PLTR)
Strategy Inc Cl A New (MSTR)

View all positions for Belvedere Trading

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
State Street Corporation
Geode Capital Management
Federated Investors
Sio Capital Management
Millennium Management
Susquehanna International
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc

View all funds holding Aquestive Therapeutics